About intercure ltd - INCR
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.
INCR At a Glance
InterCure Ltd.
85 Medinat ha-Yehudim Street
Herzliya, Tel Aviv 4676670
| Phone | 972-77-460-5012 | Revenue | 64.52M | |
| Industry | Medical Specialties | Net Income | -18,314,671.84 | |
| Sector | Health Technology | Employees | 320 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
INCR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.159 |
| Price to Book Ratio | 0.705 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -6.049 |
| Enterprise Value to Sales | 1.721 |
| Total Debt to Enterprise Value | 0.523 |
INCR Efficiency
| Revenue/Employee | 201,635.804 |
| Income Per Employee | -57,233.349 |
| Receivables Turnover | 1.303 |
| Total Asset Turnover | 0.302 |
INCR Liquidity
| Current Ratio | 1.728 |
| Quick Ratio | 1.155 |
| Cash Ratio | 0.353 |
INCR Profitability
| Gross Margin | 5.88 |
| Operating Margin | -34.882 |
| Pretax Margin | -36.561 |
| Net Margin | -28.385 |
| Return on Assets | -8.564 |
| Return on Equity | -15.565 |
| Return on Total Capital | -10.969 |
| Return on Invested Capital | -12.147 |
INCR Capital Structure
| Total Debt to Total Equity | 53.255 |
| Total Debt to Total Capital | 34.749 |
| Total Debt to Total Assets | 27.722 |
| Long-Term Debt to Equity | 34.557 |
| Long-Term Debt to Total Capital | 22.549 |
Intercure Ltd in the News
Boxing legend Mike Tyson launches partnership with Israeli medical marijuana company InterCure: 'Very lucky'
Boxing legend Mike Tyson and InterCure Chairman Ehud Barak discuss their partnership to distribute the 'Tyson 2.0' marijuana brand to international markets on 'The Claman Countdown.'